Telesis Bio Investor Relations Material
Latest events
Q2 2023
Telesis Bio
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Telesis Bio Inc
Access all reports
Telesis Bio Inc., formerly Codex DNA, Inc., is a synthetic biology company. The Company designs and sells synthetic biology instruments, reagents, plasmids and associated products and services primarily to pharmaceutical and academic laboratories. Codex's platform focuses on building the industry's most powerful research automation instrumentation designed for DNA synthesis, purification and analysis in support of therapeutic development.
Latest articles
Companies That Had Their IPO in 2019: Bull Market and Tech Dominance
Discussing the stock and IPO market in 2019, and the factors that led to the overall bullish performance of stocks during the year.
3 May 2024
Microsoft's Journey to Becoming the World's Most Valuable Company
Explore Microsoft's rise from a garage startup to the world's most valuable company, highlighting Bill Gates' role in shaping the digital revolution.
3 May 2024
Bill Gates: The Man Who Put a Computer in Every Home
Explore the life of Bill Gates, from co-founding Microsoft to global philanthropy, and his lasting impact on the world.
2 May 2024
Ticker symbol
Country
đșđž United States